lonsurf
les laboratoires servier - trifluridine, tipiracil hydrochlorid - kolorektální novotvary - antineoplastická činidla - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
diflucan 100mg tvrdá tobolka
pfizer, spol. s r.o., praha array - 9971 flukonazol - tvrdá tobolka - 100mg - flukonazol
diflucan 150mg tvrdá tobolka
pfizer, spol. s r.o., praha array - 9971 flukonazol - tvrdá tobolka - 150mg - flukonazol
diflucan 50mg tvrdá tobolka
pfizer, spol. s r.o., praha array - 9971 flukonazol - tvrdá tobolka - 50mg - flukonazol
atimos 12mcg/dáv roztok k inhalaci v tlakovém obalu
chiesi pharmaceuticals gmbh, vídeň array - 14188 dihydrÁt formoterol-fumarÁtu - roztok k inhalaci v tlakovém obalu - 12mcg/dÁv - formoterol